These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glial progenitor cell-based treatment and modeling of neurological disease. Goldman SA; Nedergaard M; Windrem MS Science; 2012 Oct; 338(6106):491-5. PubMed ID: 23112326 [TBL] [Abstract][Full Text] [Related]
3. Generation of Anterior Hindbrain-Specific, Glial-Restricted Progenitor-Like Cells from Human Pluripotent Stem Cells. Yun W; Hong W; Son D; Liu HW; Kim SS; Park M; Kim IY; Kim DS; Song G; You S Stem Cells Dev; 2019 May; 28(10):633-648. PubMed ID: 30880587 [TBL] [Abstract][Full Text] [Related]
4. Glial progenitor cell-based treatment of the childhood leukodystrophies. Osorio MJ; Goldman SA Exp Neurol; 2016 Sep; 283(Pt B):476-88. PubMed ID: 27170209 [TBL] [Abstract][Full Text] [Related]
5. Glial progenitor-based repair of demyelinating neurological diseases. Keyoung HM; Goldman SA Neurosurg Clin N Am; 2007 Jan; 18(1):93-104, x. PubMed ID: 17244557 [TBL] [Abstract][Full Text] [Related]
6. How to make an oligodendrocyte. Goldman SA; Kuypers NJ Development; 2015 Dec; 142(23):3983-95. PubMed ID: 26628089 [TBL] [Abstract][Full Text] [Related]
7. Human Glial Chimeric Mice to Define the Role of Glial Pathology in Human Disease. Mariani JN; Zou L; Goldman SA Methods Mol Biol; 2019; 1936():311-331. PubMed ID: 30820907 [TBL] [Abstract][Full Text] [Related]
8. Glial progenitor cell-based repair of the dysmyelinated brain: Progression to the clinic. Goldman SA; Mariani JN; Madsen PM Semin Cell Dev Biol; 2021 Aug; 116():62-70. PubMed ID: 33414060 [TBL] [Abstract][Full Text] [Related]
9. Glial cells in the driver seat of leukodystrophy pathogenesis. Garcia LM; Hacker JL; Sase S; Adang L; Almad A Neurobiol Dis; 2020 Dec; 146():105087. PubMed ID: 32977022 [TBL] [Abstract][Full Text] [Related]
10. Modeling cognition and disease using human glial chimeric mice. Goldman SA; Nedergaard M; Windrem MS Glia; 2015 Aug; 63(8):1483-93. PubMed ID: 26010831 [TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in Demyelinating Diseases: Oxidative Stress as a Modulator of Glial Cross-Talk. Varas R; Ortiz FC Curr Pharm Des; 2019; 25(45):4755-4762. PubMed ID: 31840603 [TBL] [Abstract][Full Text] [Related]
12. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324 [TBL] [Abstract][Full Text] [Related]
13. Stem cell-based strategies for treating pediatric disorders of myelin. Goldman SA; Schanz S; Windrem MS Hum Mol Genet; 2008 Apr; 17(R1):R76-83. PubMed ID: 18632701 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of remyelination: recent insight from experimental models. Tanaka T; Yoshida S Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760 [TBL] [Abstract][Full Text] [Related]
18. Oligodendrocyte pathology in Huntington's disease: from mechanisms to therapeutics. Ferrari Bardile C; Radulescu CI; Pouladi MA Trends Mol Med; 2023 Oct; 29(10):802-816. PubMed ID: 37591764 [TBL] [Abstract][Full Text] [Related]
19. In search of human oligodendroglia for myelin repair. Buchet D; Baron-Van Evercooren A Neurosci Lett; 2009 Jun; 456(3):112-9. PubMed ID: 19429145 [TBL] [Abstract][Full Text] [Related]
20. Glial aging and its impact on central nervous system myelin regeneration. Rawji KS; Neumann B; Franklin RJM Ann N Y Acad Sci; 2023 Jan; 1519(1):34-45. PubMed ID: 36398864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]